|
Shandong Weigao Group Medical Polymer Company Limited (1066.hk) DCF Valeure
CN | Healthcare | Medical - Instruments & Supplies | HKSE
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Shandong Weigao Group Medical Polymer Company Limited (1066.HK) Bundle
Optimisez votre temps et améliorez la précision avec notre calculatrice DCF (1066HK)! En utilisant des données réelles de Shandong Weigao Group Medical Polymer Company Limited et personnalisables, cet outil vous permet de prévoir, analyser et évaluer (1066HK) comme un investisseur chevronné.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11,069.7 | 12,117.6 | 14,047.1 | 14,546.2 | 14,130.1 | 14,862.0 | 15,631.7 | 16,441.3 | 17,292.9 | 18,188.5 |
| Revenue Growth, % | 0 | 9.47 | 15.92 | 3.55 | -2.86 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
| EBITDA | 3,487.6 | 3,522.3 | 4,010.6 | 4,678.5 | 3,795.8 | 4,403.6 | 4,631.7 | 4,871.6 | 5,123.9 | 5,389.3 |
| EBITDA, % | 31.51 | 29.07 | 28.55 | 32.16 | 26.86 | 29.63 | 29.63 | 29.63 | 29.63 | 29.63 |
| Depreciation | 652.8 | 757.2 | 786.8 | 857.8 | 973.8 | 907.7 | 954.7 | 1,004.1 | 1,056.1 | 1,110.8 |
| Depreciation, % | 5.9 | 6.25 | 5.6 | 5.9 | 6.89 | 6.11 | 6.11 | 6.11 | 6.11 | 6.11 |
| EBIT | 2,834.8 | 2,765.1 | 3,223.8 | 3,820.7 | 2,822.0 | 3,496.0 | 3,677.0 | 3,867.5 | 4,067.8 | 4,278.5 |
| EBIT, % | 25.61 | 22.82 | 22.95 | 26.27 | 19.97 | 23.52 | 23.52 | 23.52 | 23.52 | 23.52 |
| Total Cash | 4,978.7 | 6,391.3 | 7,539.2 | 7,858.5 | 7,832.6 | 7,753.4 | 8,155.0 | 8,577.3 | 9,021.6 | 9,488.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 4,637.4 | 5,450.4 | 5,544.5 | 6,125.7 | .0 | 5,007.1 | 5,266.5 | 5,539.2 | 5,826.1 | 6,127.9 |
| Account Receivables, % | 41.89 | 44.98 | 39.47 | 42.11 | 0 | 33.69 | 33.69 | 33.69 | 33.69 | 33.69 |
| Inventories | 1,327.0 | 1,606.5 | 1,852.6 | 2,473.0 | 2,665.2 | 2,208.4 | 2,322.8 | 2,443.1 | 2,569.6 | 2,702.7 |
| Inventories, % | 11.99 | 13.26 | 13.19 | 17 | 18.86 | 14.86 | 14.86 | 14.86 | 14.86 | 14.86 |
| Accounts Payable | 1,318.7 | 1,973.9 | 1,814.8 | 1,923.2 | 4,613.9 | 2,585.9 | 2,719.8 | 2,860.7 | 3,008.8 | 3,164.6 |
| Accounts Payable, % | 11.91 | 16.29 | 12.92 | 13.22 | 32.65 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
| Capital Expenditure | -1,052.2 | -1,063.4 | -1,192.9 | -1,192.2 | -732.3 | -1,193.5 | -1,255.3 | -1,320.3 | -1,388.7 | -1,460.6 |
| Capital Expenditure, % | -9.5 | -8.78 | -8.49 | -8.2 | -5.18 | -8.03 | -8.03 | -8.03 | -8.03 | -8.03 |
| Tax Rate, % | 15.5 | 15.5 | 15.5 | 15.5 | 15.5 | 15.5 | 15.5 | 15.5 | 15.5 | 15.5 |
| EBITAT | 2,327.4 | 2,311.7 | 2,581.9 | 3,182.9 | 2,384.6 | 2,891.9 | 3,041.6 | 3,199.2 | 3,364.9 | 3,539.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2,717.7 | 1,568.3 | 1,676.4 | 1,755.4 | 11,250.1 | -3,972.3 | 2,501.2 | 2,630.8 | 2,767.0 | 2,910.4 |
| WACC, % | 6.08 | 6.1 | 6.06 | 6.1 | 6.11 | 6.09 | 6.09 | 6.09 | 6.09 | 6.09 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 5,031.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 2,969 | |||||||||
| Terminal Value | 72,595 | |||||||||
| Present Terminal Value | 54,020 | |||||||||
| Enterprise Value | 59,051 | |||||||||
| Net Debt | -3,011 | |||||||||
| Equity Value | 62,063 | |||||||||
| Diluted Shares Outstanding, MM | 4,519 | |||||||||
| Equity Value Per Share | 13.73 |
Benefits You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-populated financial data for Shandong Weigao Group Medical Polymer Company Limited (1066HK).
- Accurate Financial Data: Access to both historical performance metrics and forward-looking projections (displayed in the highlighted cells).
- Flexible Forecasting Options: Adjust key assumptions like revenue growth rate, EBITDA percentage, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Shandong Weigao Group Medical Polymer Company Limited (1066HK).
- Professional Grade Tool: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive User Interface: Organized for straightforward navigation and ease of use, complete with detailed instructions.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models for in-depth analysis.
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital worksheet with adjustable parameters.
- Customizable Forecast Assumptions: Edit growth rates, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specifically for Shandong Weigao Group Medical Polymer Company Limited (1066HK).
- User-Friendly Dashboard and Charts: Visual representations highlight essential valuation metrics for streamlined analysis.
How It Works
- 1. Download the Template: Obtain and open the Excel file featuring Shandong Weigao Group Medical Polymer Company Limited's preloaded data.
- 2. Adjust Assumptions: Modify critical inputs such as growth rates, WACC, and capital expenditures relevant to [1066HK].
- 3. Retrieve Instant Results: The DCF model automatically computes intrinsic value and NPV for [1066HK].
- 4. Explore Different Scenarios: Analyze various forecasts to evaluate different valuation possibilities for [1066HK].
- 5. Present with Assurance: Share professional valuation insights for [1066HK] to strengthen your decision-making process.
Why Opt for This Calculator?
- Designed for Experts: A sophisticated tool favored by industry analysts, CFOs, and consultants.
- Authentic Data: Historical and projected financials of Shandong Weigao Group Medical Polymer Company Limited (1066HK) preloaded for precise analysis.
- Scenario Simulation: Effortlessly test various forecasts and assumptions.
- Insightful Results: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Clear, step-by-step guidance to assist you throughout the process.
Who Can Benefit from Shandong Weigao Group Medical Polymer Company Limited (1066HK)?
- Investors: Make informed investment choices with a reliable valuation framework.
- Financial Analysts: Streamline your analysis with a customizable DCF model at your fingertips.
- Consultants: Easily modify the template for effective client presentations or detailed reports.
- Healthcare Enthusiasts: Enhance your knowledge of medical polymer applications through practical examples.
- Educators and Students: Utilize this resource as a hands-on learning aid in finance and healthcare courses.
Contents of the Template
- Historical Data: Provides insights into Shandong Weigao Group Medical Polymer Co. Ltd.'s past financial performance and foundational forecasts.
- DCF and Levered DCF Models: Comprehensive templates for determining the intrinsic value of Shandong Weigao Group Medical Polymer Co. Ltd. (1066HK).
- WACC Sheet: Pre-defined calculations for Weighted Average Cost of Capital.
- Editable Inputs: Adjust essential parameters such as growth rates, EBITDA percentages, and CAPEX assumptions.
- Quarterly and Annual Statements: A detailed analysis of Shandong Weigao Group Medical Polymer Co. Ltd.'s financial statements.
- Interactive Dashboard: Dynamically visualize valuation outcomes and forecasts.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.